Teva Pharmaceutical Industries Ltd. (TEVA) Wins FDA Nod For Xgeva Biosimilar

Teva received FDA approval for DEGEVMA (denosumab-adet), a biosimilar to Xgeva, and plans to launch it alongside PONLIMSI in the U.S. in the coming months.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of Teva’s pivot toward biosimilars, adding another FDA-cleared asset. A la…